Zoetis Inc. (ZTS)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 12:07PM EDT. Market open.
| Previous Close | 158.50 |
| Open | 163.10 |
| Bid | 169.67 x 1100 |
| Ask | 169.89 x 1100 |
| Day's Range | 161.38 - 169.96 |
| 52 Week Range | 144.80 - 201.92 |
| Volume | |
| Avg. Volume | 3,651,670 |
| Market Cap | 77.119B |
| Beta (5Y Monthly) | 0.85 |
| PE Ratio (TTM) | 33.29 |
| EPS (TTM) | 5.07 |
| Earnings Date | May 02, 2024 |
| Forward Dividend & Yield | 1.73 (1.09%) |
| Ex-Dividend Date | Apr 18, 2024 |
| 1y Target Est | 216.70 |
Investor's Business DailyWhy Zoetis, Fluffy's Drugmaker, Just Reversed Its Recent Bad Fortune
Zoetis stock reversed its recent bad fortune Thursday, rising after the pet-drug maker beat first-quarter expectations.
ZacksCompared to Estimates, Zoetis (ZTS) Q1 Earnings: A Look at Key Metrics
The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Barrons.comZoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine
The animal health firm has had a tough year. Shares have plunged in response to negative media reports about an important new medicine.
© 2024 Yahoo. All rights reserved.